Literature DB >> 17459927

Viral alteration of cellular translational machinery increases defective ribosomal products.

Peter Berglund1, Diana Finzi, Jack R Bennink, Jonathan W Yewdell.   

Abstract

Here we show that cells expressing genes inserted into Semliki Forest virus (SFV) vectors generate a large fraction of defective ribosomal products (DRiPs) due to frequent initiation on downstream Met residues. In monopolizing the host cell translational machinery, SFV reduces levels of translation eukaryotic initiation factor 4E (eIF4E), diminishes phosphorylation of ribosome subunit S6, and phosphorylates translation initiation factor eIF2alpha. We show that the last event is required for SFV mistranslation of inserted genes. Downstream initiation is suppressed by fusing inserted genes with the open reading frame encoding the SFV capsid, demonstrating that one function of the capsid element is to enable ribosomes to initiate translation in the proper location. These results show that in modifying translation, viral vectors can unpredictably increase the generation of truncated polypeptides and thereby the DRiP fraction of inserted gene products, which can potentially affect their yield, therapeutic efficacy, and immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459927      PMCID: PMC1933321          DOI: 10.1128/JVI.00137-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Translational control is required for the unfolded protein response and in vivo glucose homeostasis.

Authors:  D Scheuner; B Song; E McEwen; C Liu; R Laybutt; P Gillespie; T Saunders; S Bonner-Weir; R J Kaufman
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

2.  Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.

Authors:  Tatiana N Golovina; E John Wherry; Timothy N J Bullock; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

Review 3.  Alphavirus-based vaccines.

Authors:  Kenneth Lundstrom
Journal:  Curr Opin Mol Ther       Date:  2002-02

4.  An activity-dependent switch to cap-independent translation triggered by eIF4E dephosphorylation.

Authors:  John R Dyer; Stephan Michel; Wenjau Lee; Vincent F Castellucci; Nancy L Wayne; Wayne S Sossin
Journal:  Nat Neurosci       Date:  2003-03       Impact factor: 24.884

Review 5.  Alphavirus DNA and particle replicons for vaccines and gene therapy.

Authors:  J M Polo; J P Gardner; Y Ji; B A Belli; D A Driver; S Sherrill; S Perri; M A Liu; T W Dubensky
Journal:  Dev Biol (Basel)       Date:  2000

6.  Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters.

Authors:  K I Kamrud; J W Hooper; F Elgh; C S Schmaljohn
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

7.  Ribosomal protein S6 associates with alphavirus nonstructural protein 2 and mediates expression from alphavirus messages.

Authors:  Stephanie A Montgomery; Peter Berglund; Clayton W Beard; Robert E Johnston
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

8.  Control of PERK eIF2alpha kinase activity by the endoplasmic reticulum stress-induced molecular chaperone P58IPK.

Authors:  Wei Yan; Christopher L Frank; Marcus J Korth; Bryce L Sopher; Isabel Novoa; David Ron; Michael G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-22       Impact factor: 11.205

9.  Properly folded nonstructural polyprotein directs the semliki forest virus replication complex to the endosomal compartment.

Authors:  Anne Salonen; Lidia Vasiljeva; Andres Merits; Julia Magden; Eija Jokitalo; Leevi Kääriäinen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 10.  Hijacking the translation apparatus by RNA viruses.

Authors:  Martin Bushell; Peter Sarnow
Journal:  J Cell Biol       Date:  2002-08-05       Impact factor: 10.539

View more
  24 in total

Review 1.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 2.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

Review 3.  A gripping tale of ribosomal frameshifting: extragenic suppressors of frameshift mutations spotlight P-site realignment.

Authors:  John F Atkins; Glenn R Björk
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

4.  RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis?

Authors:  Brian P Dolan; Jonathan J Knowlton; Alexandre David; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

5.  Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance.

Authors:  Jiajie Wei; Rigel J Kishton; Matthew Angel; Crystal S Conn; Nicole Dalla-Venezia; Virginie Marcel; Anne Vincent; Frédéric Catez; Sabrina Ferré; Lilia Ayadi; Virginie Marchand; Devin Dersh; James S Gibbs; Ivaylo P Ivanov; Nathan Fridlyand; Yohann Couté; Jean-Jacques Diaz; Shu-Bing Qian; Louis M Staudt; Nicholas P Restifo; Jonathan W Yewdell
Journal:  Mol Cell       Date:  2019-01-31       Impact factor: 17.970

6.  Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs.

Authors:  Ning Yang; James S Gibbs; Heather D Hickman; Glennys V Reynoso; Arun K Ghosh; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2016-03-25       Impact factor: 5.422

Review 7.  Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.

Authors:  Brian P Dolan; Jack R Bennink; Jonathan W Yewdell
Journal:  Cell Mol Life Sci       Date:  2011-03-17       Impact factor: 9.261

8.  The nature and extent of contributions by defective ribosome products to the HLA peptidome.

Authors:  Dmitry Bourdetsky; Christian E H Schmelzer; Arie Admon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-08       Impact factor: 11.205

9.  Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames.

Authors:  Damien J Zanker; Sara Oveissi; David C Tscharke; Mubing Duan; Siyuan Wan; Xiaomu Zhang; Kun Xiao; Nicole A Mifsud; James Gibbs; Lenny Izzard; Daniel Dlugolenski; Pierre Faou; Karen L Laurie; Nathalie Vigneron; Ian G Barr; John Stambas; Benoît J Van den Eynde; Jack R Bennink; Jonathan W Yewdell; Weisan Chen
Journal:  J Immunol       Date:  2019-05-15       Impact factor: 5.422

10.  Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

Authors:  Satoshi Wada; Kiyoshi Yoshimura; Edward L Hipkiss; Tim J Harris; Hung-Rong Yen; Monica V Goldberg; Joseph F Grosso; Derese Getnet; Angelo M Demarzo; George J Netto; Robert Anders; Drew M Pardoll; Charles G Drake
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.